Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNUC
11151
PUT
Frontier Nuclear and Minerals Inc
FNUC
$54.2M
| $162K | ﹤0.01% |
24,454
+17,623
| +258% | +$155K |
|
11152
VistaGen Therapeutics
VTGN
$11.2M
| $162K | ﹤0.01% |
64,781
-31,125
| -32% | -$88.1K |
|
11153
CALL
Embecta
EMBC
$286M
| $162K | ﹤0.01% |
12,700
-29,600
| -70% | -$474K |
|
|
GF
11154
New Germany Fund
GF
$191M
| $162K | ﹤0.01% |
16,489
+5,274
| +47% | +$47.3K |
|
11155
Fundamentals First ETF
KNOW
$7.49M
| $162K | ﹤0.01% |
15,371
-16,628
| -52% | -$180K |
|
11156
Global Water Resources
GWRS
$263M
| $162K | ﹤0.01% |
+15,672
| New | +$178K |
|
11157
CALL
Cardlytics
CDLX
$23.7M
| $161K | ﹤0.01% |
8,870
-5,400
| -38% | -$154K |
|
|
MGRM
11158
DELISTED
Monogram Orthopaedics
MGRM
| $161K | ﹤0.01% |
+54,845
| New | +$145K |
|
|
AGEN
11159
CALL
Agenus
AGEN
$345M
| $161K | ﹤0.01% |
106,700
-320,200
| -75% | -$922K |
|
11160
Northern Technologies International Corp
NTIC
$77.2M
| $161K | ﹤0.01% |
+15,456
| New | +$181K |
|
|
ALMS
11161
Alumis Inc
ALMS
$2.9B
| $161K | ﹤0.01% |
+26,197
| New | +$152K |
|
|
LUXE
11162
LuxExperience B.V.
LUXE
$1.06B
| $161K | ﹤0.01% |
+21,273
| New | +$197K |
|
|
FOLD
11163
CALL
DELISTED
Amicus Therapeutics
FOLD
| $161K | ﹤0.01% |
19,700
-74,500
| -79% | -$689K |
|
|
DYNCU
11164
Dynamix Corp Unit
DYNCU
| $160K | ﹤0.01% |
+15,887
| New | +$158K |
|
11165
CALL
W&T Offshore
WTI
$539M
| $160K | ﹤0.01% |
103,500
-102,600
| -50% | -$169K |
|
11166
CALL
Core Laboratories
CLB
$567M
| $160K | ﹤0.01% |
+10,700
| New | +$179K |
|
11167
Lake Shore Bancorp
LSBK
$135M
| $160K | ﹤0.01% |
+10,147
| New | +$156K |
|
11168
PUT
Virco
VIRC
$93M
| $160K | ﹤0.01% |
16,900
-900
| -5% | -$9.37K |
|
11169
Valaris Ltd Warrants
VAL.WS
$845M
| $160K | ﹤0.01% |
+31,355
| New | +$199K |
|
11170
PUT
Genie Energy
GNE
$391M
| $160K | ﹤0.01% |
+10,600
| New | +$155K |
|
|
DMB
11171
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$195M
| $160K | ﹤0.01% |
15,091
+2,779
| +23% | +$29.4K |
|
|
TRUE
11172
DELISTED
TrueCar
TRUE
| $159K | ﹤0.01% |
100,865
+14,919
| +17% | +$41.4K |
|
11173
PUT
Gran Tierra Energy
GTE
$349M
| $159K | ﹤0.01% |
32,300
-24,300
| -43% | -$139K |
|
11174
Star Group
SGU
$416M
| $159K | ﹤0.01% |
12,075
+1,829
| +18% | +$22.9K |
|
11175
Identive
INVE
$66.9M
| $159K | ﹤0.01% |
49,810
-60,553
| -55% | -$212K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.